Effect of NF-κβ inhibitor – dehydroxymethylepoxyquinomicin on iron isomaltoside toxicity toward peritoneal mesothelial cells
Saved in:
Main Authors: | Andrzej Bręborowicz, Kazuo Umezawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Renal Failure |
Online Access: | https://www.tandfonline.com/doi/10.1080/0886022X.2024.2304647 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Are the Mesothelial-to-Mesenchymal Transition, Sclerotic Peritonitis Syndromes, and Encapsulating Peritoneal Sclerosis Part of the Same Process?
by: Jesús Loureiro, et al.
Published: (2013-01-01) -
The NIMO Scandinavian Study: A Prospective Observational Study of Iron Isomaltoside Treatment in Patients with Iron Deficiency
by: Svein Oskar Frigstad, et al.
Published: (2017-01-01) -
Carvacrol attenuated haloperidol-induced Parkinson’s disease via TNF/NFκβ-NLRP3-mediated pyroptosis
by: Faisal Albaqami, et al.
Published: (2025-02-01) -
LincRNA Cox-2 Regulates Lipopolysaccharide-Induced Inflammatory Response of Human Peritoneal Mesothelial Cells via Modulating miR-21/NF-κB Axis
by: Yaoyao Bian, et al.
Published: (2019-01-01) -
HMGB2 Deficiency Mitigates Abdominal Aortic Aneurysm by Suppressing Ang-II-Caused Ferroptosis and Inflammation via NF-κβ Pathway
by: Hao Wu, et al.
Published: (2023-01-01)